ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST)

NCT00041509 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthroplasty

Interventions

DRUG: SB-424323
DRUG: Placebo

Sponsor

GlaxoSmithKline